MarketPulse

vaccine market

3 articles
The Motley FoolThe Motley Fool··Prosper Junior Bakiny

Pfizer vs. Moderna: Navigating Pharma's Post-Pandemic Pivot

Moderna's 69% YTD gain reflects mRNA vaccine upside, while Pfizer's 6.3% dividend offers stability as COVID revenues fade. Choice depends on risk appetite.
MRKPFEMRNAbiotechclinical trials
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Infanrix Vaccines Poised for Strong Growth as Emerging Markets Expand Immunization Programs

Infanrix vaccines experience robust growth driven by rising birth rates in emerging economies, expanded immunization programs, and increased vaccine manufacturing investments through 2035.
GSKcold chain logisticsInfanrix
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

RotaTeq Vaccine Market Poised for Sustained Growth Through 2030 Amid Rising Immunization Demand

RotaTeq rotavirus vaccine market expanding rapidly driven by rising immunization initiatives, increased disease cases, and manufacturing localization. North America leads; Asia-Pacific fastest-growing region.
MRKAsia Pacific growthvaccine market